Assessment of the Reporting Quality of Randomized, Controlled Trials of Percutaneous Patent Foramen Ovale Closure for the Treatment of Migraine Based on the CONSORT Statement
by Eirini Beneki, MSc, MD, PhD(c); Kyriakos Dimitriadis, MD, PhD;
by Eirini Beneki, MSc, MD, PhD(c); Kyriakos Dimitriadis, MD, PhD;
by Dr. Yousra Benmakhlouf, PhD; Dr. Achraf Laghmich, PhD*; Kaoutar
by Eric Morse, MD; Graeme Christianson, BSE; Melissa Olivadoti, PhD;
by Yetty Ramli, MD, SpN(K); Fadhlan Rusdi, MD, SpN; Mohammad
by Prof. Yuliarni Syafrita, Sp.N(K); Harnavi Harun, Sp.PD-KGH, FINASIM; Restu
by Houda Bekkari , PhD; Dr. Yousra Benmakhlouf, PhD; Prof.
by Uzma Ilyas, PhD scholar, and Prof. Dr. Saima Dawood,
by CAROLYN O’DONNELL, PharmD; TAMMIE LEE DEMLER, BS, PharmD, MBA,
by Maria Fe Garcia-Rada, MPS, and Robert E. Litman, MD
by Uzma Ilyas, PhD scholar; Farwa Aslam, MS; Muqadas Fatima,